👨‍🏫 This keynote session will be chaired by @DemosthenesBouros, @StamatisNickLiossis, @ArgyrisTzouvelekis , and @ParaskeviVoulgari, and will be attended by speakers @TheofanisKaragiorgas, dimitroulas , Tzilas, Kouranos, allanore yannick and @Sara Tomassetti.

🌍 In parallel we are running a specialised training session in collaboration with the Scleroderma Clinial Trials Consortium 'MRSS-Training and standardisation course'. Led by Dan Furst with experts Marco matucci cerini Dr. Dinesh Khanna Professor Francesco Del Galdo allanore yannick C. Denton #Prague2024

Excited to speak about osteoporosis at the upcoming Rheumatology Update Meeting in Amsterdam! Join us to delve into the latest insights and advancements. Details here rheumatology-update-europe.eu #RheumatologyUpdate LauraCoates Benjamin Terrier Cristina Ponte allanore yannick Bimba Hoyer

📢Annonce REF
Poste d'assistant à temps plein dans le service de rhumato Hôpital Cochin-Port-Royal AP-HP à partir de novembre 2024
allanore yannick Avouac Jérôme Briot karine
Plus d'info 🔽🔽🔽🔽🔽

Great experience in Hyderabad, participating to the Indian annual meeting and sharing experience about systemic sclerosis management

🔔 P0956 Effects of B cell depletion by CD-19 targeted CAR-T cells in murine models of systemic sclerosis

🔷 B-cell therapies failed to show efficacy in the Fra2 transgenic mice
🔷 The exacerbated Fra-2 lung inflammatory burden stimulated activated CD-19-targeted CAR-T cells

CS

📢13th November 2023
👐Welcome to the 3rd day of #ACR2023 !
♦️Do not miss the session dedicated to personalized medicine in scleroderma: preclinical models
📍Room 32A-B
⏰8-9 am
World Scleroderma Foundation

🌟 A heartfelt 👏 'Thank You' from the organizers, Professors A. Low, M. Kuwana, M. Matucci Cerinic , for your incredible participation in this joint e-Masterclass by WSF and APLAR . With over 🎉 500 subscribers from all around the globe, it's been an outstanding success! 🌍🌍🌏

🌟 Exciting News! Join us for the 'Invited Lectures' session on the topic:'Similarity and Difference between Idiopathic and #CTD -Associated #ILDs ,' moderated by @Kamal Solanki and Yasuhiro Kondoh
🤸‍♂️ Get ready to delve into a comprehensive discussion

masterclasses.worldsclerofound.org

🏃‍♂️Get ready for some enlightening insights in our 'Invited Lectures' session, moderated by Meng Tao Li and @Zoe Brown. We have an impressive lineup of speakers who are experts in their fields. Don't miss out on this opportunity to learn from some of the best in the field!

📚 Brace yourselves for an in-depth exploration of the latest treatments for Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD)! Moderated by S. Proudman and J. Raja , this session promises to be a game-changer. Here's a sneak peek at our stellar lineup!

NEW Personal View—Alain Lescoat and colleagues discuss parameters and candidate definitions for a conceptual framework of pre-scleroderma; such a paradigm could offer a new preventive medicine perspective in the management of #SystemicSclerosis thelancet.com/journals/lanrh…

Our Oct issue is live! Including a #GBDstudy on #RheumatoidArthritis , cohort studies on tapering in #SLE and #gout care during the #pandemic , vascular imaging in #SystemicSclerosis , plus much more! thelancet.com/journals/lanrh…
Cover by Grace Russell (Grace Russell)

Happy to share a new EUSTAR database release: the coexistence of 2 autoimmune diseases seems to mitigate the respective phenotypes. Systemic sclerosis and primary biliary cholangitis: Longitudinal data to determine the outcomes pubmed.ncbi.nlm.nih.gov/37744053/

Thanks to an international effort, we provide some data about MCTD-ILD which is poorly known, showing that about one third have a progressive phenotype

The phenotype of mixed connective tissue disease patients having associated interstitial lung disease pubmed.ncbi.nlm.nih.gov/37696231/

Contribution to treatment algorithm in systemic sclerosis thanks to a great meeting with stimulating debate: Is cyclophosphamide still the gold standard in early severe rapidly progressive systemic sclerosis? pubmed.ncbi.nlm.nih.gov/37690478/

Great results particularly on the vascular component of arsenic trioxide in a mouse model of severe lung complications related to systemic sclerosis. Follow-up studies are expected !
pubmed.ncbi.nlm.nih.gov/37700377/

📢SSc Clinical Science Journal Club
💥September hot news by shiri keret
🎯WIN- Patients with SSc sine scleroderma have a comparable rate of ILD vs lcSSc!
Find out more 👉 pubmed.ncbi.nlm.nih.gov/37378994/
#EUSTAR#YIGs#JC YIGs
Alain Lescoat

Relevance of circulating Semaphorin 4A for rheumatoid arthritis response to treatment pubmed.ncbi.nlm.nih.gov/37669994/

Great collaborative study highlighting a new biomarker candidate in rheumatoid arthritis